Clinical Trial Update: Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children [Phase 2, Phase 3]

View source ↗

Summary

A pediatric trial evaluating chemotherapy for recurrent or refractory yolk sac tumor has completed Phase 2 and Phase 3 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor
• Yolk Sac Tumor

Snippet

Sponsor: Shandong First Medical University | Conditions: Germ Cell Tumor, Yolk Sac Tumor | Phase 2, Phase 3 | Status: COMPLETED